The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Human Coagulation Factor VII-Global Market Insights and Sales Trends 2025
Synopsis
Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activated factor VII is also available, but does not play any considerable role in the market.
The global Human Coagulation Factor VII market size is expected to reach US$ 4368 million by 2029, growing at a CAGR of 9.6% from 2023 to 2029. The market is mainly driven by the significant applications of Human Coagulation Factor VII in various end use industries. The expanding demands from the Hemophilia A, Spontanous / Trauma, Surgical and Others, are propelling Human Coagulation Factor VII market. Recombinant Factor VIII, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Plasma-derived Factor VIII segment is estimated at % CAGR for the next seven-year period.
Europe and North America are the largest region of Human Coagulation Factor VII, with about 40% market share respectively. NovoNordisk is the major manufacturer of industry.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Coagulation Factor VII, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Coagulation Factor VII market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Coagulation Factor VII market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Coagulation Factor VII sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Coagulation Factor VII covered in this report include NovoNordisk. etc.
The global Human Coagulation Factor VII market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
NovoNordisk
Global Human Coagulation Factor VII market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Coagulation Factor VII market, Segment by Type:
Recombinant Factor VIII
Plasma-derived Factor VIII
Global Human Coagulation Factor VII market, by Application
Hemophilia A
Spontanous / Trauma
Surgical
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Human Coagulation Factor VII manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Human Coagulation Factor VII in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activated factor VII is also available, but does not play any considerable role in the market.
The global Human Coagulation Factor VII market size is expected to reach US$ 4368 million by 2029, growing at a CAGR of 9.6% from 2023 to 2029. The market is mainly driven by the significant applications of Human Coagulation Factor VII in various end use industries. The expanding demands from the Hemophilia A, Spontanous / Trauma, Surgical and Others, are propelling Human Coagulation Factor VII market. Recombinant Factor VIII, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Plasma-derived Factor VIII segment is estimated at % CAGR for the next seven-year period.
Europe and North America are the largest region of Human Coagulation Factor VII, with about 40% market share respectively. NovoNordisk is the major manufacturer of industry.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Coagulation Factor VII, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Coagulation Factor VII market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Coagulation Factor VII market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Coagulation Factor VII sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Coagulation Factor VII covered in this report include NovoNordisk. etc.
The global Human Coagulation Factor VII market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
NovoNordisk
Global Human Coagulation Factor VII market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Coagulation Factor VII market, Segment by Type:
Recombinant Factor VIII
Plasma-derived Factor VIII
Global Human Coagulation Factor VII market, by Application
Hemophilia A
Spontanous / Trauma
Surgical
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Human Coagulation Factor VII manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Human Coagulation Factor VII in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Human Coagulation Factor VII Market Overview
1.1 Human Coagulation Factor VII Product Overview
1.2 Human Coagulation Factor VII Market Segment by Type
1.2.1 Recombinant Factor VIII
1.2.2 Plasma-derived Factor VIII
1.3 Global Human Coagulation Factor VII Market Size by Type
1.3.1 Global Human Coagulation Factor VII Market Size Overview by Type (2018-2029)
1.3.2 Global Human Coagulation Factor VII Historic Market Size Review by Type (2018-2023)
1.3.3 Global Human Coagulation Factor VII Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Coagulation Factor VII Sales Breakdown by Type (2018-2023)
1.4.2 Europe Human Coagulation Factor VII Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Human Coagulation Factor VII Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Human Coagulation Factor VII Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Human Coagulation Factor VII Sales Breakdown by Type (2018-2023)
2 Global Human Coagulation Factor VII Market Competition by Company
2.1 Global Top Players by Human Coagulation Factor VII Sales (2018-2023)
2.2 Global Top Players by Human Coagulation Factor VII Revenue (2018-2023)
2.3 Global Top Players by Human Coagulation Factor VII Price (2018-2023)
2.4 Global Top Manufacturers Human Coagulation Factor VII Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Coagulation Factor VII Market Competitive Situation and Trends
2.5.1 Human Coagulation Factor VII Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Coagulation Factor VII Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Coagulation Factor VII as of 2022)
2.7 Date of Key Manufacturers Enter into Human Coagulation Factor VII Market
2.8 Key Manufacturers Human Coagulation Factor VII Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Coagulation Factor VII Status and Outlook by Region
3.1 Global Human Coagulation Factor VII Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Human Coagulation Factor VII Historic Market Size by Region
3.2.1 Global Human Coagulation Factor VII Sales in Volume by Region (2018-2023)
3.2.2 Global Human Coagulation Factor VII Sales in Value by Region (2018-2023)
3.2.3 Global Human Coagulation Factor VII Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Human Coagulation Factor VII Forecasted Market Size by Region
3.3.1 Global Human Coagulation Factor VII Sales in Volume by Region (2024-2029)
3.3.2 Global Human Coagulation Factor VII Sales in Value by Region (2024-2029)
3.3.3 Global Human Coagulation Factor VII Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Human Coagulation Factor VII by Application
4.1 Human Coagulation Factor VII Market Segment by Application
4.1.1 Hemophilia A
4.1.2 Spontanous / Trauma
4.1.3 Surgical
4.1.4 Others
4.2 Global Human Coagulation Factor VII Market Size by Application
4.2.1 Global Human Coagulation Factor VII Market Size Overview by Application (2018-2029)
4.2.2 Global Human Coagulation Factor VII Historic Market Size Review by Application (2018-2023)
4.2.3 Global Human Coagulation Factor VII Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Coagulation Factor VII Sales Breakdown by Application (2018-2023)
4.3.2 Europe Human Coagulation Factor VII Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Human Coagulation Factor VII Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Human Coagulation Factor VII Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Human Coagulation Factor VII Sales Breakdown by Application (2018-2023)
5 North America Human Coagulation Factor VII by Country
5.1 North America Human Coagulation Factor VII Historic Market Size by Country
5.1.1 North America Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Human Coagulation Factor VII Sales in Volume by Country (2018-2023)
5.1.3 North America Human Coagulation Factor VII Sales in Value by Country (2018-2023)
5.2 North America Human Coagulation Factor VII Forecasted Market Size by Country
5.2.1 North America Human Coagulation Factor VII Sales in Volume by Country (2024-2029)
5.2.2 North America Human Coagulation Factor VII Sales in Value by Country (2024-2029)
6 Europe Human Coagulation Factor VII by Country
6.1 Europe Human Coagulation Factor VII Historic Market Size by Country
6.1.1 Europe Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Human Coagulation Factor VII Sales in Volume by Country (2018-2023)
6.1.3 Europe Human Coagulation Factor VII Sales in Value by Country (2018-2023)
6.2 Europe Human Coagulation Factor VII Forecasted Market Size by Country
6.2.1 Europe Human Coagulation Factor VII Sales in Volume by Country (2024-2029)
6.2.2 Europe Human Coagulation Factor VII Sales in Value by Country (2024-2029)
7 Asia-Pacific Human Coagulation Factor VII by Region
7.1 Asia-Pacific Human Coagulation Factor VII Historic Market Size by Region
7.1.1 Asia-Pacific Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Human Coagulation Factor VII Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Human Coagulation Factor VII Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Human Coagulation Factor VII Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Coagulation Factor VII Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Human Coagulation Factor VII Sales in Value by Region (2024-2029)
8 Latin America Human Coagulation Factor VII by Country
8.1 Latin America Human Coagulation Factor VII Historic Market Size by Country
8.1.1 Latin America Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Human Coagulation Factor VII Sales in Volume by Country (2018-2023)
8.1.3 Latin America Human Coagulation Factor VII Sales in Value by Country (2018-2023)
8.2 Latin America Human Coagulation Factor VII Forecasted Market Size by Country
8.2.1 Latin America Human Coagulation Factor VII Sales in Volume by Country (2024-2029)
8.2.2 Latin America Human Coagulation Factor VII Sales in Value by Country (2024-2029)
9 Middle East and Africa Human Coagulation Factor VII by Country
9.1 Middle East and Africa Human Coagulation Factor VII Historic Market Size by Country
9.1.1 Middle East and Africa Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Human Coagulation Factor VII Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Human Coagulation Factor VII Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Human Coagulation Factor VII Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Coagulation Factor VII Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Human Coagulation Factor VII Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 NovoNordisk
10.1.1 NovoNordisk Company Information
10.1.2 NovoNordisk Introduction and Business Overview
10.1.3 NovoNordisk Human Coagulation Factor VII Sales, Revenue and Gross Margin (2018-2023)
10.1.4 NovoNordisk Human Coagulation Factor VII Products Offered
10.1.5 NovoNordisk Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Coagulation Factor VII Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Coagulation Factor VII Industrial Chain Analysis
11.4 Human Coagulation Factor VII Market Dynamics
11.4.1 Human Coagulation Factor VII Industry Trends
11.4.2 Human Coagulation Factor VII Market Drivers
11.4.3 Human Coagulation Factor VII Market Challenges
11.4.4 Human Coagulation Factor VII Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Coagulation Factor VII Distributors
12.3 Human Coagulation Factor VII Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
